New combo aims to shrink tough rectal tumors before surgery
NCT ID NCT01941641
First seen Nov 17, 2025 · Last updated May 20, 2026 · Updated 26 times
Summary
This study tested a powerful chemotherapy combination (FOLFOXIRI) followed by chemoradiation before surgery in 40 people with high-risk rectal cancer. The goal was to shrink tumors enough to allow complete removal. Researchers measured how well the tumors responded and tracked side effects and long-term outcomes like survival and recurrence.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECTAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Department of Clinical Oncology
Hong Kong, Hong Kong
Conditions
Explore the condition pages connected to this study.